Effect of Acute Red Raspberry Consumption on Post-prandial Oxidative Stress

Sponsor
University of Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT01242033
Collaborator
Unity Health Toronto (Other)
8
1
5
28
8.7

Study Details

Study Description

Brief Summary

Eight healthy adult subjects will be given a meal of one, two or four cups red raspberries, or two slices white bread with or without 200 mg vitamin C, after an overnight fast and consumption of a low polyphenol diet for two days. Blood samples will be taken at various time points over an eight hour period to measure oxidative stress and antioxidant levels in the blood. Each subject will attend 5 study visits with one week intervals and be given each meal in a random order. It is hypothesized that raspberry consumption at higher doses will greater protect against meal-induced oxidative stress compared to bread controls.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: red raspberries
  • Dietary Supplement: bread controls
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
An Acute Intervention Study Investigating the Effect of Red Raspberry Consumption on Post-prandial Oxidative Stress
Study Start Date :
Feb 1, 2010
Actual Primary Completion Date :
Mar 1, 2010
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: one cup red raspberries

treatment meal consists of one cup red raspberries

Dietary Supplement: red raspberries
single serving of one, two or four cups red raspberries

Experimental: two cups red raspberries

treatment meal consists of two cups red raspberries

Dietary Supplement: red raspberries
single serving of one, two or four cups red raspberries

Experimental: four cups red raspberries

treatment meal consists of four cups red raspberries

Dietary Supplement: red raspberries
single serving of one, two or four cups red raspberries

Placebo Comparator: bread

treatment meal consists of two slices white bread

Dietary Supplement: bread controls
two slices white bread alone or with 200 mg vitamin C supplement

Active Comparator: vitamin C

treatment meal consists of two slices white bread and 200 mg vitamin C in the form of supplemental ascorbic acid

Dietary Supplement: bread controls
two slices white bread alone or with 200 mg vitamin C supplement

Outcome Measures

Primary Outcome Measures

  1. change in antioxidant capacity from baseline (-0.25 h) [-0.25, 0.25, 0.5, 1, 2, 4 hours post-intake]

    plasma antioxidant capacity measured using the 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) radical cation assay and expressed in Trolox Equivalents (TE)

Secondary Outcome Measures

  1. change in lipid peroxidation from baseline (-0.25 h) [-0.25, 0.25, 0.5, 1, 2, 4 hours post-intake]

    serum thiobarbituric acid reactive substances (TBARS) measured as an indicator of the lipid peroxidation product malondialdehyde (MDA)

  2. change in thiols compared to baseline (-0.25 h) [-025, 0.25, 0.5, 1, 2, 4 hours post-intake]

    plasma thiols quantified by 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) assay as an indicator of the level of protection against protein oxidation

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy adults
Exclusion Criteria:
  • blood pressure greater than 120/80 mm Hg

  • body mass index greater than 24.9 kg/m^2

  • history of any chronic disease

  • currently taking medications

  • allergy to fruit

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Nutrition and Risk Factor Modification Centre; St. Michael's Hospital Toronto Ontario Canada M5C 2T2

Sponsors and Collaborators

  • University of Toronto
  • Unity Health Toronto

Investigators

  • Principal Investigator: A V Rao, PhD, University of Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01242033
Other Study ID Numbers:
  • 24774
First Posted:
Nov 16, 2010
Last Update Posted:
Dec 6, 2010
Last Verified:
Nov 1, 2010

Study Results

No Results Posted as of Dec 6, 2010